Galectin-3 is a galactose/lactose-binding protein (M r ϳ30,000), identified as a required factor in the splicing of pre-mRNA. In the LG1 strain of human diploid fibroblasts, galectin-3 could be found in both the nucleus and the cytoplasm of young, proliferating cells. In contrast, the protein was predominantly cytoplasmic in senescent LG1 cells that have lost replicative competence through in vitro culture. Incubation of young cells with leptomycin B, a drug that disrupts the interaction between the leucine-rich nuclear export signal and its receptor, resulted in the accumulation of galectin-3 inside the nucleus. In senescent cells, galectin-3 staining remained cytoplasmic even in the presence of the drug, thus suggesting that the observed localization in the cytoplasm was due to a lack of nuclear import. In heterodikaryons derived from fusion of young and senescent LG1 cells, the predominant phenotype was galectin-3 in both nuclei. These results suggest that senescent LG1 cells might lack a factor(s) specifically required for galectin-3 nuclear import.
INTRODUCTION
Normal human diploid fibroblasts (HDF) have a finite replicative life span during in vitro culture [1, 2] . Cells derived from embryonic tissues generally can undergo ϳ50 doublings. As the passage number in serial cultivation increases, the culture doubling time increases and the fraction of cells participating in DNA synthesis decreases. When the cells reach replicative incompetence through this process, they are considered senescent. Thus, the age of a given HDF strain is often expressed as the number of cumulative population doublings (CPD). This, in turn, is related to the passage number in serial cultivation by the regime of subculturing (split ratio, duration).
Cellular senescence in vitro is thought to parallel certain aspects of organismal aging in vivo. This view is derived from several lines of correlative evidence: (a) HDF from young donors can undergo more doublings than fibroblasts from older donors before they reach senescence [3, 4] (however, this has recently been questioned and revisited [5] ), (b) fibroblasts from humans with premature aging syndromes (e.g., Werner's syndrome) senesce after many fewer doublings than cells from age-matched controls [6] , and (c) fibroblasts from short-lived species generally senesce after fewer doublings than cells from longer-lived species [7] . Undoubtedly, in vivo aging events within the organism are much more complex than those that can be studied by looking at in vitro cellular senescence alone. The cell culture model does offer, however, a system for identifying and analyzing certain functions that are altered with age in vivo. For example, the induction of heat shock protein 70 by hyperthermia in fibroblasts is significantly lower in late passage fibroblasts and in cells from old donors than in early passage cells and cells from young donors [8] . The decline in heat shock protein 70 expression during cellular senescence in vitro and in cells derived from old human subjects is paralleled by a decrease in the levels of the heat shock transcription factor HSF1. Using ␤-galactosidase as a biomarker histochemically detectable at pH 6 only in senescent cells, Dimri et al. [9] provided evidence that senescent cells may persist and accumulate with age in vivo. Most strikingly, mutation of the SGS1 gene of yeast, in which the cell is the organism, has been shown to cause accelerated age-related changes and reduced replicative life span [10] . The SGS1 gene encodes a DNA helicase with homology to the human Werner's syndrome gene (WRN), in which mutations lead to a disease with premature aging symptoms.
In previous studies, we had reported the nuclear localization of galectin-3 and its activity in the nucleus as a pre-mRNA splicing factor [11] . We have also compared the expression and localization of galectin-3 in quiescent versus proliferating fibroblasts in two systems: (a) serum-starved mouse 3T3 fibroblasts arrested in G 0 and their serum-stimulated counterparts undergoing DNA replication and (b) young SL66 hu-man fibroblasts (CPD ϳ18) versus senescent SL66 cells (CPD ϳ60). Serum-starved 3T3 fibroblasts expressed a low level of galectin-3, most of which was cytoplasmic. Upon serum stimulation, there was marked elevation in galectin-3 protein, which was translocated to the nucleus [12] . Young SL66 cells behaved similarly to mouse 3T3 cells [13] . However, senescent SL66 cells appeared to have lost the normal proliferation-dependent regulation of galectin-3 expression: the level of the protein was high during serum starvation and decreased after serum stimulation. In nonsynchronized (random) cultures, galectin-3 could not be detected in either the nucleus or the cytoplasm of the senescent SL66 fibroblasts [13] .
A similar analysis has now been performed on another strain of HDF, the LG1 cells. Two surprising results were obtained: (a) the regulation of galectin-3 expression was similar to that of mouse 3T3 fibroblasts and was independent of the age of the LG1 cells and (b) the nuclear localization of galectin-3 was age-dependent: in young LG1 cells, galectin-3 could be found in both the nucleus and the cytoplasm, whereas galectin-3 appeared to be excluded from the nuclei of senescent LG1 cells. In the present communication, we document these findings and provide a preliminary analysis of the basis for this nuclear exclusion phenomenon.
MATERIALS AND METHODS
Cell culture. The HDF cell strain, designated LG1 [14] , was a gift from Drs. J. J. McCormick and V. M. Maher (Michigan State University). The cells were received at passage 8 (P8), with a calculated CPD of 16. Through P20 (corresponding to a CPD of 40), the LG1 cells were seeded at 3.5 ϫ 10 3 cells/cm 2 and serially passaged at a split ratio of 1:4. After P20, the cells were seeded at 2 ϫ 10 3 cells/cm 2 and serially passaged at a split ratio of 1:3. Cells at P24 through P28 have undergone 47 through 54 CPDs. The LG1 cells were cultured in MEM (minimum essential Eagle's medium supplemented with 0.2 mM L-aspartic acid, 0.2 mM L-serine, and 1 mM sodium pyruvate) containing 1.8 mM CaCl 2 and 10% bovine calf serum (Hyclone) at 37°C and 5% CO 2 . Proliferating LG1 cells were made quiescent by removing the complete growth medium, washing twice with phosphate-buffered saline (PBS; 140 mM NaCl, 2.68 mM KCl, 10 mM Na 2 HPO 4 , 1.47 mM KH 2 PO 4 , pH 7.4), and incubating in starvation medium (MEM containing 0.1 mM CaCl 2 and 0.2% bovine calf serum). The quiescent cells were induced to reenter the cell cycle in a synchronous fashion by the addition of complete growth medium.
Several independent methods were used to assess the proliferative versus quiescent states of the cells. (i) Direct determination of cell number in a corpuscle counting chamber [15] . (ii) Determination of the DNA content of single cells by fluorescence-activated cell sorting after staining with propidium iodide (PI) [16] . (iii) Bulk determination of DNA synthesis, as assayed by the incorporation of [ 3 H]thymidine [15] . LG1 cells cultured in 15 ϫ 80-mm cluster dishes were pulse-labeled for 2 h with 20 Ci [ 3 H]thymidine (2 Ci/mmol). After the labeling period, the cells were washed extensively with PBS, detached from the growth surface with 0.5% trypsin, and collected by vacuum filtration over a Whatman GF/C filter. The cells were washed three times with ice-cold PBS; the cells were then lysed and the DNA was precipitated with ice-cold 10% trichloroacetic acid. The filters were washed with methanol, air-dried, and subjected to scintillation counting [15] . (iv) Determination of DNA synthesis at the level of single cells, as measured by the incorporation of 5-bromo-2Ј-deoxyuridine (BrdU). The cells were seeded onto coverslips and cultured in complete growth medium in six-well (9.6 cm 2 /well) cluster dishes. After 48 h, the medium was removed and replaced with complete growth medium containing 100 M BrdU. The cells were cultured for an additional 24 or 48 h and were then processed for indirect immunofluorescence staining with anti-BrdU antibodies (see below).
Antibody reagents. Anti-Mac2 is a rat monoclonal antibody directed against an epitope mapped to the amino-terminal domain of galectin-3 [17, 18] . The antibody was purified from the culture supernatant of the hybridoma line M3/38.1.2.8.HL.2, obtained from the American Type Culture Collection (TIB 166; Rockville, MD). AntiBrdU is a mouse monoclonal antibody directed against 5-bromo-2Ј-deoxyuridine-5Ј-monophosphate (Boehringer Mannheim; clone BMC-9318). Human autoimmune serum reactive with the Sm antigens of the small nuclear ribonucleoprotein complexes (snRNPs) was purchased from The Binding Site. The following mouse monoclonal antibodies were purchased from Transduction Laboratories: (a) mouse anti-Ran was used to detect the GTP-binding protein Ran, involved in nucleocytoplasmic transport, and (b) mouse anti-karyopherin-␤ was used to detect the ␤ subunit of the receptor for nuclear localization sequences. Anti-actin is a polyclonal rabbit antiserum raised against calf thymus actin [19] ; anti-lactate dehydrogenase (LDH) is a polyclonal rabbit antiserum raised against pig muscle LDH and was a gift from Dr. John Wilson (Michigan State University).
Immunofluorescence microscopy.
LG1 cells were seeded onto coverslips and cultured in complete growth medium in six-well (9.6 cm 2 /well) cluster dishes for 48 h. Leptomycin B (LMB) was a generous gift from Dr. Minoru Yoshida (University of Tokyo). In experiments using LMB, the cells were cultured overnight in the presence of the antibiotic (8 ng/ml; 15.2 nM). All steps described below were performed at room temperature and, unless otherwise specified, each step was followed by two washes with PBS: (a) the medium was removed from the cultures, (b) the cells were fixed for 20 min with 4% paraformaldehyde in PBS, (c) the cells were permeabilized with 0.5% Triton X-100 in PBS for 4 min, (d) the fixed and permeabilized cells were incubated in 1.5 M HCl for 30 min, and (e) the cells were then incubated in T-TBS (10 mM Tris, pH 7.5, 0.5 M NaCl, 0.05% Tween 20) containing 0.2% gelatin for at least 1 h.
The cells were incubated for 1 h in a humidified chamber with the primary antibody (anti-Mac2, anti-BrdU, anti-Sm, or anti-LDH) by inverting the coverslips onto 180 l of T-TBS containing 0.2% gelatin and the appropriate dilution of the antibody. The cells were washed three times (15 min each) with T-TBS and then incubated for 1 h in T-TBS containing 0.2% gelatin and the appropriate secondary antibody. Secondary antibodies conjugated with fluorescein isothiocyanate (FITC) or Cy3 were used at the following dilutions: (i) FITCconjugated goat anti-rat IgG, affinity purified and absorbed against human and mouse immunoglobulin (Boehringer Mannheim), at 1:4000; (ii) Cy3-conjugated sheep anti-mouse IgG, affinity purified and absorbed with human serum proteins (Sigma), at 1:1500; (iii) FITC-conjugated goat anti-human IgG (EY Laboratories) at 1:1000; and (iv) FITC-conjugated goat anti-rabbit IgG, affinity purified (Boehringer Mannheim) at 1:2000. The cells were then washed three times (15 min each) with T-TBS and mounted onto glass microscope slides with PermaFluor (Immunon). In some experiments, the cells were further stained with PI following the secondary antibody treatment. To do this, the cells were washed twice with T-TBS (15 min each) and incubated with PI (32 g/ml) in T-TBS containing 0.2% gelatin for 30 min. The cells were washed with T-TBS (2 min each) and mounted onto glass slides with PermaFluor. The fluorescence staining was analyzed using an Insight Plus laser scanning confocal microscope (Meridian Instruments).
Preparation of cell extracts and immunoblotting analysis. For the preparation of cell extracts, LG1 cells were washed twice with PBS, detached from the growth surface with 0.5% trypsin, and collected by centrifugation. After three washes with PBS, the number of cells in each sample was determined. The samples were normalized in terms of cell number and were then incubated in a modified Laemmli [20] buffer (10% glycerol, 2% sodium dodecyl sulfate, 0.25 M sodium phosphate, pH 6.8, 10 mM ␤-mercaptoethanol), sonicated four times (15 s each) on ice, and then incubated for 15 min in a sand bath at 95°C.
For immunoblot analysis, polypeptides were resolved by 12.5% SDS-PAGE [20] and electrophoretically transferred to a PVDF membrane (Immobilon-P; Millipore) using a transfer buffer containing 25 mM Tris, 193 mM glycine, and 10% methanol (pH 8.3). The membrane was blocked for several hours in T-TBS containing 10% nonfat dry milk. After several brief washes with T-TBS, the membrane was incubated with the primary antibody, diluted in T-TBS containing 1% nonfat dry milk, for 1 h at room temperature. After five washes (15 min each) with T-TBS, the membrane was incubated for 1 h at room temperature with T-TBS containing 1% nonfat dry milk and horseradish peroxidase-conjugated secondary antibodies. After extensive washing with T-TBS, the proteins were visualized using the Renaissance chemiluminescence detection system (New England Nuclear Life Sciences).
Polyethylene glycol-mediated cell fusions. The procedure used for cell fusion represents a modified version of the protocols described by Stein and Yanishevsky [21] and Pereira-Smith and Smith [22] . The LG1 cells were seeded into 15 ϫ 80-mm culture dishes in complete growth medium. The cells were grown to ϳ5 ϫ 10 3 cells/cm 2 . The cells to be used for fusion were first tagged with recognizable beads (Polysciences): (a) P18 cells with Fluoresbrite NYO carboxylate microspheres (1.75 m average diameter) and (b) P27 cells with Polybead microspheres (2 m average diameter). To allow the cells to ingest the beads, the incubation was carried out overnight, at a concentration of ϳ500 beads per cell. The cells were washed with PBS to remove the noningested beads and detached from the growth surface with 0.25% trypsin. The cells were replated onto 22-mm 2 glass coverslips, placed in 35-mm wells of a cluster dish, at a total cell concentration of 5 ϫ 10 4 cells/well in complete growth medium. After overnight culture, the medium was removed and the cells were washed three times with PBS. The cells were then treated for 55 s with 45% polyethylene glycol (PEG; molecular weight 1000; Fluka Chemical Corp.) in serum-free MEM. The cells were washed three times with PBS and then complete growth medium was added. The cells were incubated for 24 -48 h before they were prepared for immunofluorescence (see above).
Several levels of controls were performed. First, sham fusions were carried out, in which PEG was omitted during the fusion step (the 55-s treatment was simply MEM, containing neither serum nor PEG). Second, P19 LG1 cells were grown and fused to form homokaryons to test the effect of PEG on the subcellular distribution of galectin-3. Similarly, P27 LG1 cells also were fused to form homokaryons to determine the effect of PEG on these cells.
RESULTS

Galectin-3 Expression in LG1 Human Fibroblasts
In this study, data collected on young LG1 cells were derived from P17, P18, and P19, corresponding to CPD values of 34, 36, and 38, respectively. These cells had a high replicative capacity, as assayed at the single-cell level by the incorporation of BrdU. After a 48-h labeling period, 85% or more of P17-P19 cells incorporated BrdU in their nuclei (see, for example, Table 1 ). Data also were collected from LG1 cells at P24 through P27, with CPD values of 47 to 52. Approximately 15% of P24 -P27 cells incorporated BrdU. Therefore, these cells exhibited a low replicative capacity and were used as the senescent cell population.
The expression of galectin-3 in LG1 cells between P17 and P19 was sensitive to the proliferative state of the cultures (Fig. 1 ). Upon serum withdrawal from random cultures, galectin-3 levels decreased over the course of 72 h. Quiescence in the serum-starved cultures was ascertained by flow cytometry and by determination of cell number. Upon serum addition and reentry of these cells into the cell cycle, galectin-3 levels increased during the G 1 phase of the cell cycle (Fig. 1A) , well before the onset of S phase, as revealed by the incorporation of [ 3 H]thymidine (Fig. 1C ). Therefore, the proliferation-dependent expression of galectin-3 in young LG1 cells (e.g., P19) is similar to that documented for mouse 3T3 fibroblasts [12] and the HDF strain SL66 [13] .
At high passage number, however, the two HDF strains (LG1 and SL66) behaved quite differently in terms of galectin-3 expression during serum starvation and restimulation. Figure 1B shows the Western blot data for galectin-3 levels in LG1 cells at P24 as a function of serum starvation and restimulation. It should be noted that the various lanes of the Western blots in Fig. 1 were loaded on the basis of equal cell number. Since LG1 at P24 are larger in size than the corresponding cells at P19, the amount of protein, including galectin-3, appears greater in the P24 cells (compare, for example, the samples derived from nonsynchronized/random cultures in Figs. 1A and 1B). This also is evident comparing the levels of actin (Figs. 1A and 1B). Like their counterparts at P19, LG1 cells at P24 also showed a decrease in galectin-3 levels during the 72-h serum starvation and a marked elevation upon serum restimulation (Fig. 1B) . Thus, both young and senescent LG1 cells express galectin-3 and this expression responds to serum induction. This pattern of galectin-3 expression in LG1 HDF is quite different from our previous observation, which documented little or no detectable galectin-3 in senescent SL66 cells after serum induction [13] .
Nuclear versus Cytoplasmic Localization of Galectin-3 in Young and Senescent LG1 Cells
In addition to Western blot analysis, we have monitored galectin-3 at the single-cell level in LG1 HDF by immunofluorescence using confocal microscopy. During these studies, we made the observation that galectin-3 appeared to be excluded from the nuclei of the majority of the senescent LG1 cells. In addition, there appeared to be a direct correlation, at the single-cell level, between galectin-3 in the nucleus and the proliferative state of the cell, as assayed by the incorporation of BrdU and staining with monoclonal anti-BrdU antibodies (Table 2) . Representative micrographs illustrating cells analyzed for BrdU staining and galectin-3 staining are shown in Fig. 2 . The following description refers to the columns (proceeding from left to right) in both Table 2 and Fig. 2 . For P17: (a) ϳ90% of the cells were BrdU positive and each one of these cells showed galectin-3 in both the nucleus and the cytoplasm (with more intense galectin-3 staining in the nucleus), (b) ϳ1% of the cells were BrdU negative and had galectin-3 in the nucleus, and (c) ϳ10% of the cells were BrdU negative and galectin-3 appeared to be exclusively cytoplasmic.
The corresponding analysis for P24 cells showed: (a) ϳ15% of the cells were BrdU positive and showed nuclear and cytoplasmic staining for galectin-3, (b) 1% or less of the cells showed no BrdU staining but had galectin-3 in the nucleus, and (c) ϳ84% of the cells were negative for both BrdU and nuclear galectin-3. Thus, in the majority of these senescent cells, DNA synthesis had ceased and galectin-3 appeared to be all cytoplasmic.
It should be noted that in the double immunofluorescence experiments described above, BrdU was detected with a mouse monoclonal antibody directed against the nucleotide plus Cy3-conjugated sheep antimouse immunoglobulin. Galectin-3 was detected with a rat monoclonal antibody directed against the aminoterminal portion of the polypeptide plus FITC-conjugated goat anti-rat immunoglobulin. Several control experiments, crucial to the interpretation of the results, were performed. First, LG1 cells (P17 and P24) did not exhibit autofluorescence, after fixation with paraformaldehyde; there was no fluorescence signal when any of the key reagents (BrdU, primary antibody, or secondary antibody) was omitted. Second, the binding of the fluorescent secondary antibody depended on the presence of the primary antibody. Fluorescein-conjugated goat anti-rat immunoglobulin yielded no fluorescence in the absence of rat monoclonal anti-galec- LG1 cells were seeded in complete growth medium (MEM, 1.8 mM CaCl 2 , 10% bovine calf serum). P19 and P24 cells were seeded at 3.5 ϫ 10 3 and 2.0 ϫ 10 3 cells/cm 2 , respectively; because of size differences between these cells, both cultures were approximately 20% confluent at these densities. After 24 h, cultures were subjected to serum starvation by removing the medium, washing twice with PBS, and incubating in starvation medium (MEM, 0.1 mM CaCl 2 , 0.2% bovine calf serum). Cells were stimulated to reenter the cell cycle by addition of complete growth medium. Cells from nonsynchronized/random (R) cultures and cultures at various times after starvation or restimulation were harvested, washed twice with PBS, and counted. Extracts from an equal number of cells were prepared for SDS-PAGE and immunoblotting with antibodies directed against galectin-3 and actin. The binding of the primary antibodies was revealed with horseradish peroxidase-conjugated secondary antibodies and detected using a chemiluminescence system. (C) DNA synthesis, as assayed by the incorporation of [ 3 H]thymidine (2 Ci/mmol, 20 Ci per 15 ϫ 80-mm dish; 2-h pulse), in P19 cells to determine the S phase of the cell cycle for the synchronized population.
tin-3 and similarly, Cy3-conjugated sheep anti-mouse immunoglobulin yielded no signal in the absence of mouse anti-BrdU. Thus, these secondary antibodies did not bind nonspecifically to cellular components. Third, there was no cross-reaction between the fluorescein-conjugated goat anti-rat immunoglobulin and the mouse monoclonal anti-BrdU. Conversely, there was also no cross-reaction between the Cy3-conjugated sheep anti-mouse immunoglobulin and the rat antigalectin-3. Finally, given the filter cutoffs used and over the scale of intensities studied, there was no "bleeding over" between the fluorescence of the green (fluorescein) and the red (Cy3) channels.
In one set of experiments, scanning confocal microscopy collected images through 10 consecutive focal planes to verify the subcellular localization of galectin-3. In both P17 (Fig. 3A) and P24 cells (Fig. 3C) , those cells that yielded fluorescent nuclear galectin-3 staining also showed intense nuclear staining as the plane of focus cut through the middle sections of the cell. For P17 (Fig. 3B) and P24 (Fig. 3D ) cells that yielded nuclei devoid of fluorescence, there appeared to be a "big black hole" through the middle sections of the scanning confocal analysis. These results serve to ascertain that the nuclear galectin-3 fluorescence was truly due to the protein in the nucleus and, conversely, that the nucleus was indeed devoid of the protein when galectin-3 appeared to be excluded from that compartment.
Effect of Leptomycin B on the Localization of Galectin-3
Several possibilities were considered to explain the nuclear plus cytoplasmic localization of galectin-3 in young cells and the predominantly cytoplasmic localization in senescent cultures. For example, senescent LG1 cells could be: (a) deficient in nuclear import, (b) deficient in nuclear retention, or (c) enhanced in nuclear export of galectin-3. We have recently reported that galectin-3 is rapidly and selectively exported from the nucleus and that this export is inhibited by LMB [23] . This antibiotic inhibits the interaction of the CRM1 nuclear export receptor with the leucine-rich nuclear export signal [24 -26] . Indeed, a putative leucine-rich nuclear export signal, with the requisite spacing of leucine/isoleucine residues, can be found in the amino acid sequences of the galectin-3 homologs of various species [23] . On this basis, we tested the effect of LMB on the nuclear versus cytoplasmic distribution of galectin-3 in young and senescent cells.
For P17 cells, incubation with LMB (8 ng/ml, 15.2 nM; 22 h) resulted in the accumulation of galectin-3 in the nucleus, as revealed by the almost exclusively nuclear staining (Fig. 4) . In contrast, the predominantly cytoplasmic localization of galectin-3 in P26 cells was unaltered by LMB. If galectin-3 were imported into the nucleus of P26 cells, one would have expected an accumulation of the protein in the nucleus when export is inhibited by LMB. Thus, it appears that the observed LG1 cells at P17 and P24 were seeded at 3.5 ϫ 10 3 and 2 ϫ 10 3 cells/cm 2 , respectively. The cells were labeled with BrdU (100 M; 48 h). The cells were fixed and stained simultaneously with rat anti-galectin-3 (Gal-3) and mouse anti-BrdU. The binding of the rat monoclonal antibody was detected with FITC-labeled goat anti-rat immunoglobulin, yielding the green fluorescence. The binding of the mouse monoclonal antibody was detected with Cy3-conjugated sheep anti-mouse immunoglobulin, yielding the red fluorescence. For both P17 and P24, three categories of cells were identified: (a) cells whose nuclei were positive for both BrdU and galectin-3, (b) cells whose nuclei were positive for galectin-3 but negative for BrdU, and (c) cells whose nuclei were negative for both BrdU and galectin-3. Bar, 20 m.
cytoplasmic localization in senescent cultures was most likely due to lack of nuclear import.
Formation of Heterokaryons Derived from Fusion between Young and Senescent Cells
Given the apparent deficiency in nuclear import of galectin-3 in senescent LG1 cells, we hypothesized that they may lack factors required for the nuclear import of the protein. Alternatively, the senescent cells could contain a cytoplasmic anchor for galectin-3, sequestering the protein from the nuclear import pathway. Both of these possibilities would result in an apparent nuclear exclusion phenotype, as assayed by immunofluorescence. To distinguish between these possibilities, we generated heterokaryons derived from fusion between young and senescent LG1 cells. The individual cell types used for the fusion were first tagged by the incorporation of recognizable beads, so that we could determine whether a cell containing two nuclei was a homokaryon (derived from fusion of the same cell type) or a heterokaryon (derived from fusion of distinct cell types).
LG1 cells at P17 were induced to ingest green fluorescent beads. The green fluorescence from the beads can be detected in the same channel as that for fluorescein-conjugated goat anti-rat immunoglobulin, used to detect galectin-3. Figure 5A shows that the green beads are easily recognizable (highlighted in figure by a white arrowhead) and, more importantly, distinguishable from the fluorescence due to fluorescein used to locate galectin-3. The boundary of the nucleus is defined by concurrent staining of the cell with PI (yielding the red nucleus in Fig. 5A ) and thus, the presence of galectin-3 in the nucleus of the bead-tagged cell is readily determined. A cell with a few (ϳ4) beads (Fig. 5A, top ) and a cell with many (Ͼ15) beads (Fig.  5A, bottom) are shown.
LG1 cells at P26 were induced to ingest nonfluorescent beads. These beads appear as black dots (highlighted by a white arrow) when viewed in the fluorescein channel, against a green fluorescent background representing galectin-3 in the cytoplasm (Fig. 5B) . The nucleus, whose boundary is defined by PI labeling in the red channel, is devoid of galectin-3 in these senes- cent cells. A cell with a few (ϳ8) beads (Fig. 5B, top ) and a cell with many (Ͼ25) beads (Fig. 5B, bottom) are shown.
The nonfluorescent (black) beads used to tag P26 cells have an average diameter of ϳ2 m; the fluorescent (green) beads used to tag P17 cells have an average diameter of ϳ1.75 m. However, in the fluorescence micrographs shown in Fig. 5 (and in Fig. 6 as well), the green beads appear larger than the black beads. The is due to the halo effect or fluorescent flare of the green beads. In any case, we had surveyed a number of other beads, varying in size and in fluorescent properties, and found that ingestion of beads of approximately the same size represented the best way to tag the young and senescent LG1 cells.
Analysis of Galectin-3 Localization in Heterokaryons
The various parts of Fig. 6 provide examples of the galectin-3 localization patterns and the scoring system that will be used to analyze the results detailed in Table 3 . nuclei are devoid of galectin-3. Figs. 6C-6E represent heterodikaryons formed by fusion of P18 and P27 LG1 cells; both green and black beads are observed, highlighted by the arrowheads and arrows, respectively. We score a heterodikaryon only if it contains at least seven of each kind of bead. Both nuclei of the heterodikaryon shown in Fig. 6C contain galectin-3 . In  Fig. 6D , one of the two nuclei of the heterodikaryon contains galectin-3 while the other nucleus is devoid of the protein. Finally, Fig. 6E shows a heterodikaryon in which neither of the nuclei contains galectin-3. Table 3 shows that in any given experiment, we monitored the nuclear versus cytoplasmic localization of galectin-3 in: (a) P19 cells not exposed to any fusogen (PEG), in which the overwhelming majority of the cells are monokaryons; (b) P19 cells treated with PEG, in which only homokaryons can be formed and observed (along with unfused monokaryons); (c) P27 cells not exposed to PEG; (d) P27 cells treated with PEG; and (e) P19 and P27 cells in coculture treated with PEG, in which we scored only heterodikaryons (although monokaryons and homokaryons also are present). Higher order karyons (tri-, tetra-, etc.) comprise only a very small fraction of the total number of fused cells and are excluded from the analyses. The results of one experiment are presented in Table 3 . We have repeated this experiment three times, with essentially the same results. Even within a single experiment, there are many numbers to consider. In the interest of brevity (and clarity), we state the major conclusions below and we provide an analysis of the theoretical and actual results in Fig. 7 .
The following general statements can be derived from analysis of the data in Table 3 (Fig. 7) . Approximately 63% of the population is predicted to show the 1 N ϩ and 1 N Ϫ phenotype [(0.86 ϫ 0.67) ϩ (0.14 ϫ 0.33)]. Finally, ϳ9% (0.14 ϫ 0.67) of the heterodikaryons should show N Ϫ in both nuclei. The experimental results yielded far more heterodikaryons exhibiting N ϩ in both nuclei, far fewer of the 1 N ϩ and 1 N Ϫ phenotype, and the expected percentage of cells with N Ϫ in both nuclei (Table 3 and Fig. 7 ). The difference between the theoretical and the actual results points to an enhancement of nuclear localization of the galectin-3 polypeptide in the heterokaryons. On this basis, we conclude that the components of the P19 cells can alter the regulation of nucleocytoplasmic distribution of the galectin-3 in the fused cells.
Analysis of Nuclear and Cytoplasmic Markers and of DNA Synthesis in Heterokaryons
We have carried out a similar analysis on markers of the nucleus and cytoplasm. The Sm antigen is an epitope, recognized by human autoimmune serum, found on some of the core polypeptides of the snRNPs. Immunofluorescence staining for Sm in LG1 cells always localized the epitope to the nucleus, irrespective of CPD (P17 or P26), with or without PEG treatment, and in heterodikaryons (Fig. 8) . Likewise, staining for LDH always localized the enzyme to the cytoplasm. Therefore, the exclusion of galectin-3 from the nucleus of senescent LG1 cells and its altered nucleocytoplasmic distribution in heterodikaryons derived from P19 and P27 fusions do not reflect a general loss of nuclear versus cytoplasmic segregation.
Because our experimental results suggested that senescent cells might be deficient in a factor(s) required for nuclear import and that the cytoplasm of young cells can rectify this apparent deficiency in heterokaryons, we analyzed two candidate factors, Ran and karyopherin-␤. Ran is a small GTP-binding protein (M r ϳ25,000) involved in nucleocytoplasmic transport and karyopherin-␤ is one subunit (M r ϳ97,000) of the receptor for the nuclear localization signal such as that identified on the SV40 large T antigen (see, for exam- a Nϩ, galectin-3 in nucleus; NϪ, no nuclear galectin-3; 2Nϩ, both nuclei contain galectin-3; 2NϪ, both nuclei devoid of galectin-3; 1Nϩ 1NϪ, one of the two nuclei contains galectin-3 and the other nucleus is devoid of it.
FIG. 7.
Comparison of the theoretical and actual phenotypes of galectin-3 localization. The theoretical values were calculated from the percentage of monokaryons exhibiting nuclear localization of galectin-3 when P19 or P27 cells were treated with PEG (see Table  3 ). The actual values were determined from heterodikaryons derived from PEG-mediated fusion of P19 and P27 cells. * 2 analysis showed that difference from the theoretical value was significant (P Ͻ 0.001). ** Not significant (P Ͻ 0.025) by 2 analysis.
ple, the review by Izaurralde and Adam [27] ). Using immunoblotting, we found little or no difference in the levels of Ran and karyopherin-␤ expressed in P18 and P27 LG1 cells (data not shown). In addition, immunofluorescence analysis of Ran in young and senescent HDFs showed no difference in the subcellular distribution and overall staining pattern. Thus, it seems unlikely that the altered nuclear versus cytoplasmic distribution of galectin-3 in senescent LG1 cells can be ascribed to these two key import factors. Finally, we also have monitored DNA synthesis in heterokaryons derived from fusion of P19 and P27 LG1 cells. Our BrdU labeling experiments show that, in the majority of the dikaryons analyzed, neither of the nuclei were labeled (Table 1) . This is in agreement with previous reports [21, 22, 28] documenting that the senescent cell nucleus is dominantly suppressive when fused with a cell capable of undergoing DNA replication.
DISCUSSION
The key findings of the present report include: (a) In the LG1 strain of HDF, galectin-3 expression is diminished during quiescence brought about by serum starvation and is induced upon readdition of serum. This pattern is observed independent of the replicative capacity of the cells. (b) Although expressed in senescent LG1 cells, the protein appears to be excluded from the nuclei of these cells. This is in contrast to young LG1 cells, in which 80 -90% of the cells showed galectin-3 in the nucleus (and in the cytoplasm). (c) In heterodikaryons derived from fusion of young and senescent LG1 cells, the predominant phenotype was galectin-3 in both nuclei. The results of these analyses, together with other control experiments, suggest that the components of young LG1 cells can alter the nucleocytoplasmic distribution of galectin-3 by supplying some factor(s) required for the nuclear localization of the protein.
Comparison of the results of the present study with a previous study performed on another strain of HDF (SL66) highlights the interesting fact that nuclei of senescent HDF, no longer capable of undergoing DNA synthesis, do not contain galectin-3. This is achieved by one of two ways. In the case of SL66, the expression of galectin-3 is simply downregulated, as assayed at the level of the mRNA by Northern blotting or at the level of the protein by Western blotting [13] . In the case of LG1, on the other hand, the regulation appears to be much more subtle (and perhaps more exquisite): while the polypeptide of galectin-3 continues to be expressed in LG1 cells no longer undergoing DNA synthesis, the protein appears to be excluded from the nuclei of these cells, resulting in a predominantly cytoplasmic localization.
Nuclear exclusion of galectin-3 has been observed in cancer cells of the colon [29] . In human colonic epithelium, the level of expression of galectin-3 is increased in the progression from normal mucosa to adenoma to carcinoma. More strikingly, while galectin-3 is concentrated in the nuclei of the differentiated cells of normal epithelia, it is present only in the cytoplasm and appears to be excluded from the nuclei of adenoma and carcinoma cells. In addition to galectin-3, at least three other examples can be cited to draw analogies to this phenomenon of nuclear exclusion.
First, patients with Werner syndrome prematurely develop a variety of the major age-related diseases,
FIG. 8.
Analysis of the localization of nuclear and cytoplasmic markers. The localization of Sm was determined with human autoimmune serum reactive against snRNPs and the localization of lactate dehydrogenase was determined using antiserum raised against LDH. The experimental conditions for PEG treatment of P17 and P26 cells are the same as those described in the legend to Fig. 6. including atherosclerosis, osteoporosis, type II diabetes, and malignant neoplasms [6] . Early graying and hair loss, skin atrophy, and aged appearance also are manifested by these individuals. Fibroblasts from these patients have shorter replicative life spans, which are similar to the life spans of corresponding cells taken from elderly individuals. The WRN gene has been cloned; the amino acid sequence of the encoded polypeptide shows significant similarity to those of DNA helicases [30] . Indeed, ATP-dependent 3Ј 3 5Ј helicase activity has been demonstrated in vitro [31] . The WRN gene product is normally found in the nucleolus [32, 33] or nucleoplasm [34] but there is impaired nuclear localization of defective DNA helicases in Werner's syndrome cells [35] .
Second, the wild-type p53 protein can act to negatively regulate cell proliferation and function as a suppressor of transformation and tumorigenesis. Mutations at the p53 locus have been thought of as the most common mechanism to inactivate the negative regulatory effects of p53 on cell proliferation. However, breast cancers contain p53 mutations in only about 30% of the cases. Moreover, many breast cancers show a reduction to homozygosity at the p53 locus, but more than 60% of such breast cancers retain the wild-type p53 allele. On this basis, it was reasoned that there are mechanisms, other than mutations directly affecting the activity of the p53 protein, to overcome or bypass its negative regulation of cell growth [36] . Indeed, it appears that some breast cancers that contain the wild-type form of p53 protein may inactivate its tumor-suppressing activity by sequestering this protein in the cytoplasm, away from its site of action in the cell nucleus. More strikingly, the same study also detected cytoplasmic p53 in normal lactating breast tissue, suggesting that estrogen-mediated cell proliferation in this particular physiological situation may use nuclear exclusion to inactivate p53. Recent studies have revealed that another oncoprotein, Hdm2, plays an important role in determining the nuclear versus cytoplasmic distribution of p53 and its degradation in the cytoplasm (for a review, see [37] ). The Hdm2 polypeptide, as well as the p53 polypeptide, each contain a functional nuclear export signal. Thus, it remains to be determined what fraction of the cases in which p53 is cytoplasmic can be ascribed to an impairment of nuclear import versus an enhancement of nuclear export.
Finally, mutations in the breast cancer-1 (BRCA1) gene are thought to be responsible for families who are predisposed to breast cancer (familial breast carcinomas). Immunostaining of nonmalignant breast tissues showed BRCA1 in the nucleus and cytoplasm of normal breast epithelial cells [38] . Familial breast carcinoma cells appear to downregulate the expression of the protein. In nonfamilial breast cancer, more than half of the cases displayed nuclear and cytoplasmic staining, some 20% displayed only cytoplasmic staining, and another 20% showed no BRCA1 staining at all. More strikingly, the loss of BRCA1 from the nucleus of nonfamilial breast carcinomas has been reported [38, 39] . The loss of nuclear staining in these samples appears to be more common in high-grade breast carcinomas and in patients with evidence of pathological lymph nodes.
The mechanism by which galectin-3 is excluded from the nucleus of senescent LG1 cells is not known. However, several key pieces of information seem particularly important. The first is that incubation of young cells in the presence of LMB accumulates galectin-3 in the nucleus. In contrast, LMB has no apparent effect on the nuclear versus cytoplasmic distribution of galectin-3 in senescent cultures; the protein remains predominantly cytoplasmic. These results argue against an enhanced export pathway being responsible for the observed cytoplasmic localization in senescent LG1 cells. Instead, it appears that galectin-3 is simply not imported into the nucleus of these cells.
The second fact is that the galectin-3 polypeptide, derived from P27 LG1 cells, is not intrinsically impaired in terms of nuclear import. This was demonstrated by monitoring selectively the human galectin-3 polypeptide in heterodikaryons derived from fusion between mouse 3T3 and human LG1 (at P27) cells (K. P. Openo, unpublished observations). NCL-GAL3 is a mouse monoclonal antibody that: (a) immunoblots galectin-3 from extracts of human but not mouse cells and (b) stains human HeLa cells and LG1 fibroblasts but not mouse 3T3 fibroblasts under immunofluorescence. Thus, it appears that the NCL-GAL3 antibody specifically recognizes human galectin-3 but not its murine counterpart. Using this antibody to stain heterodikaryons derived from fusion between mouse 3T3 cells and human LG1 cells (at P27), we found human galectin-3 in both nuclei. This indicates that the galectin-3 polypeptide in senescent human fibroblasts can be imported into the nucleus.
The final key fact is our present observation that heterokaryons derived from fusions between young and senescent LG1 cells show a phenotype in which both nuclei contain galectin-3. This strongly suggests that the senescent LG1 cells might lack a factor(s) required for nuclear import, which must be supplied by the young cells. It seems unlikely that the deficient factor might be Ran or karyopherin-␤, inasmuch as immunoblotting experiments indicate that both are expressed equivalently in young and senescent LG1 cells. Finally, there does not appear to be any alteration in the nuclear versus cytoplasmic distribution of other nuclear proteins, such as the core polypeptides of the snRNPs. Thus, the nuclear import of galectin-3 may require specialized components and/or mechanisms.
In previous studies, Agrwal [40] had conjugated recombinant galectin-3 with rhodamine and the result-ing fluorescent derivative was tested for nuclear localization after: (a) microinjection into intact mouse 3T3 fibroblasts (in vivo assay) or (b) incubation with 3T3 cells permeabilized by digitonin (in vitro assay). Microinjected galectin-3 accumulated in the nucleus of some recipient cells, whereas fluorescently labeled human serum albumin failed to do so in any of the cells. Fluorescently labeled human serum albumin conjugated with a peptide containing the nuclear localization signal of SV40 large T antigen (rh-HSA-NLS) was translocated into the nucleus in 100% of the microinjected cells. Thus, while galectin-3 introduced into 3T3 cells can be imported into the nucleus, its nuclear localization properties were different from those documented for HSA-NLS. Galectin-3 and HSA-NLS were also different in terms of requirements and conditions of nuclear import in the in vitro assay. While rh-HSA-NLS was imported into the nucleus in an ATP-and cytosol-dependent fashion, little or no nuclear transport of rh-galectin-3 could be demonstrated. Thus, it appears that the S100 cytosolic fraction (containing the nuclear import factors such as karyopherins, Ran, and NTF2) used in the in vitro assay could not supply the factor(s) necessary for the import of galectin-3, while the cytosol of microinjected cells could indeed fulfill the requirements of nuclear transport.
In our analysis of heterokaryons following fusion between young and senescent LG1 cells, the dominant phenotype is galectin-3 in the nucleus (N ϩ in both nuclei), corresponding to the phenotype of the young cells. This observation is in contrast to the dominance of the senescent phenotype in heterokaryons between replicative and postreplicative HDFs when assayed for nuclear DNA synthesis. Entry into S phase is blocked in nuclei of heterokaryons containing at least one senescent cell [21, 22, 28] . Using P19 and P27 LG1 cells, we have performed parallel analyses for galectin-3 localization and for BrdU incorporation in heterokaryons derived from a single fusion experiment. We have ascertained that, indeed, there is a divergence of dominant phenotypes: (a) young-cell phenotype is dominant with respect to galectin-3 nuclear localization and (b) senescent-cell phenotype is dominant with respect to DNA synthesis and cell cycle progression. This phenotype divergence suggests that galectin-3 nuclear localization is not sufficient for restoration of nuclear DNA synthesis in the senescent HDF.
Thus, the significance of excluding galectin-3 from the nucleus of senescent cells remains to be explored, particularly in terms of its role in processing nuclear RNA molecules. Although no direct evidence has been reported to link cellular senescence and problems in pre-mRNA splicing, it has been shown that senescent WI-38 HDFs have a posttranscriptional block in the expression of the proliferating cell nuclear antigen gene [41] , reflecting, possibly, a splicing defect. In addition, alternative splicing variants of fibronectin are specifically expressed in senescent IMR-90 HDFs [42] . Given our documentation on the "lack" of galectin-3 in nuclei of SL66 [13] and LG1 cells, this protein certainly becomes an intriguing candidate for altering the premRNA processing events in senescent cells.
